lorcaserin(856681-05-5)is an orally administered agent and a selective 5-ht2c receptor agonist for the treatment of obesity. it had been approved for marketing in us by fda on 27 june in 2012. in clinical studies, lorcaserin has demonstrated efficacy in obese and overweight populations by promoting weight loss and improving metabolic parameters, and it is well tolerated.
3-oxocyclopentanecarboxylic acid basic information |
product name: | 3-oxocyclopentanecarboxylic acid |
synonyms: | 3-oxocyclopentane-1-carboxylic acid;3-oxocyclopentanecarboxylic acid;3-oxo-1-cyclopentanecarboxylic acid;[(4-methyl-2-pyrimidinyl)sulfanyl]acetic acid;3-ketocyclopentanecarboxylic acid;3-oxocyclopentanecar;3-oxocyclopentanecarboxyl...;1-carboxy-3-oxocyclopentane |
cas: | 98-78-2 |
mf: | c6h8o3 |
mw: | 128.13 |
einecs: | |
product categories: | pharmacetical;c6;carbonyl compounds;carboxylic acids |
mol file: | 98-78-2.mol |
3-oxocyclopentanecarboxylic acid chemical properties |
melting point | 59-62 °c(lit.) |
cas database reference | 98-78-2(cas database reference) |
safety information |
risk statements | 36/37/38 |
safety statements | 26-36/37/39 |
wgk germany | 3 |
msds information |
provider | language |
---|---|
3-oxo-1-cyclopentanecarboxylic acid | english |
sigmaaldrich | english |
3-oxocyclopentanecarboxylic acid usage and synthesis |
chemical properties | white powder |
3-oxocyclopentanecarboxylic acid preparation products and raw materials |